Cboe UK CHF

Basilea Pharmaceutica AG (BSLNZ.XC)

Compare
41.05 -0.40 (-0.97%)
At close: December 23 at 4:19:51 PM GMT

Research Analysis

Revenue vs. Earnings

Revenue 29.15M
Earnings --
Q2'06
Q4'18
Q4'20
0
10M
20M
30M
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----55
Avg. Estimate ----203.32M221.99M
Low Estimate ----196.34M213.38M
High Estimate ----207M231.19M
Year Ago Sales ----157.6M203.32M
Sales Growth (year/est) ----29.01%9.18%

EPS Trend

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
BSLNZ.XC --------
S&P 500 5.00%12.00%2.10%12.20%